Gilead Sciences (GILD) Sale and Maturity of Investments (2009 - 2026)
Gilead Sciences' Sale and Maturity of Investments - Total came in at $1.03 billion for Q2 2026, up 230.6% from $310 million a year earlier but down 59.9% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gilead Sciences reported Sale and Maturity of Investments - Total of $4.18 billion; for FY2025, it was $909 million, down 64.9% from FY2024.
- Sale and Maturity of Investments - Total carries a five-year compound annual growth rate of -51.2% (FY2020 to FY2025).
- Going back by year, Sale and Maturity of Investments - Total was $2.59 billion in FY2024 (+40.6%), $1.84 billion in FY2023 (-7.9%), $2 billion in FY2022 (-31.2%) and $2.91 billion in FY2021 (-91.1%).
- The five-year range for quarterly Sale and Maturity of Investments - Total is $236 million (Q3 2025) to $2.59 billion (Q1 2024).
- The fastest year-over-year change in Sale and Maturity of Investments - Total over five years came in Q1 2024 (growth of 427.9%), and the weakest in Q4 2021 (a decline of 95.0%).
- Business Quant data shows GILD's Sale and Maturity of Investments - Total at $2.56 billion (Q1 2026), $363 million (Q4 2025) and $236 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Bn |
| Mar 31, 2026 | 2.56 Bn |
| Dec 31, 2025 | 363.00 Mn |
| Sep 30, 2025 | 236.00 Mn |
| Jun 30, 2025 | 310.00 Mn |
| Mar 31, 2024 | 2.59 Bn |
| Dec 31, 2023 | 447.00 Mn |
| Sep 30, 2023 | 361.00 Mn |
| Jun 30, 2023 | 545.00 Mn |
| Mar 31, 2023 | 491.00 Mn |
| Dec 31, 2022 | 400.00 Mn |
| Sep 30, 2022 | 324.00 Mn |
| Jun 30, 2022 | 653.00 Mn |
| Mar 31, 2022 | 625.00 Mn |
| Dec 31, 2021 | 596.00 Mn |
| Sep 30, 2021 | 813.00 Mn |
| Jun 30, 2021 | 822.00 Mn |
| Mar 31, 2021 | 679.00 Mn |
| Dec 31, 2020 | 11.82 Bn |
| Sep 30, 2020 | 4.24 Bn |
API Access
Gilead Sciences Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();